Chinese team says vaccine shows promise in treating breast cancer in mice
Chinese scientists have developed a promising nanovaccine for treating an aggressive form of breast cancer in mice, achieving a tumour inhibition rate of 89.3%. This innovative approach utilises tumour cell membranes to boost the immune response of B cells, which play a crucial role in combating cancer cells. The research, conducted by the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences, addresses the challenge of enhancing B cell activation by incorporating components that stimulate the immune response.
Nanovaccines crafted from cell membranes are at the forefront of cancer treatment research. These vaccines involve extracting and transforming tumour cell membranes into nanoparticles while preserving antigens that can trigger a targeted immune response. This method holds potential for creating more personalised and effective cancer treatments, potentially using membranes from a patient's own tumour cells. However, while the approach shows significant promise, it still faces challenges, such as managing potential adverse side effects. The study represents a significant step forward in the quest for advanced cancer therapies.
via SCMP Full Text Feed
Chinese scientists have developed a promising nanovaccine for treating an aggressive form of breast cancer in mice, achieving a tumour inhibition rate of 89.3%. This innovative approach utilises tumour cell membranes to boost the immune response of B cells, which play a crucial role in combating cancer cells. The research, conducted by the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences, addresses the challenge of enhancing B cell activation by incorporating components that stimulate the immune response.
Nanovaccines crafted from cell membranes are at the forefront of cancer treatment research. These vaccines involve extracting and transforming tumour cell membranes into nanoparticles while preserving antigens that can trigger a targeted immune response. This method holds potential for creating more personalised and effective cancer treatments, potentially using membranes from a patient's own tumour cells. However, while the approach shows significant promise, it still faces challenges, such as managing potential adverse side effects. The study represents a significant step forward in the quest for advanced cancer therapies.
via SCMP Full Text Feed
